Circadian rhythm variations of intraocular pressure and therapeutic decisions: Interpretation of clinical trial results based on a statistical model;Variations nycthémérales de la pression intraoculaire et décisions thérapeutiques: Interprétation des résultats d'essais cliniques à partir d'un modèle statistique

Journal Francais d'Ophtalmologie

Volumn 27, Issue SPEC. ISS. 2, 2004, Pages

  Denis, P ^a   Berdeaux, G ^b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Alcon Research Ltd   (France)

^c NONE   (France)

Author keywords

Circadian rhythm; Diagnosis; Intraocular pressure; Therapeutic decision

Indexed keywords

PROSTAGLANDIN DERIVATIVE; TRAVOPROST; CLOPROSTENOL; DRUG DERIVATIVE; LATANOPROST; PROSTAGLANDIN F;

ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MEDICAL DECISION MAKING; STATISTICAL MODEL; BIOLOGICAL MODEL; BIOTRANSFORMATION; CHRONOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DECISION MAKING; DRUG EFFECT; GENETIC VARIABILITY; GLAUCOMA; METHODOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

BIOTRANSFORMATION; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLOPROSTENOL; DECISION MAKING; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MODELS, BIOLOGICAL; PROSTAGLANDINS F, SYNTHETIC; RANDOMIZED CONTROLLED TRIALS; VARIATION (GENETICS);

EID: 4744366688     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Qureshi IA, Xiao RX, Yang BH, Zhang J, Xiang DW, Hui JL. Seasonal and diurnal variations of ocular pressure in ocular hypertensive subjects in Pakistan. Singapore Med J, 1999;40:345-8.
2. Liu JH, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci, 1999;40:2912-7.
3. Sacca SC, Rolando M, Marietta A, Macri A, Cerqueti P, Ciurlo G. Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects.: Ophthalmologica, 1998;212:115-9.
4. De Vivero C, O'Brien C, Lanigan L, Hitchings R. Diurnal intraocular pressure variation in low-tension glaucoma. Eye, 1994;8:521-3.
5. Liu JH, Zhang X, Kripke DF, Weinreb RN. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci, 2003;44:1586-90.
6. Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma, 2000;9:134-42.
7. Wax MB, Camras CB, Fiscella RG, Girkin C, Singh K, Weinreb RN. Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure. Am J Ophthalmol, 2002;133:S1-10.
8. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica, 1999;213:76-96.
9. Konstas AG, Papapanos P, Tersis I, Houliara D, Stewart WC. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination. Ophthalmology, 2003;110:1357-60.
10. DuBiner HB , Ratliff M, Teague J, Landry T, Bergamini M, Wiener A. Travatan Administration Results in Effective Diurnal Reduction in Intraocular Pressure Over 36 Hours and Lower Pressures Up to 3.5 Days Without Further Dosing. ARVO Annual Meeting Abstract Search and Program Planner, 2002:Abstract N°1066.
11. DuBiner H, Sircy M, Landry T, et al. Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure. Clinical Therapeutics, 2004;26:84-91.
12. Orzalesi N, Rossetti L, Bottoli A, Fumagalli E, Fogagnolo P. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Arch Ophthalmol, 2003;121:453-7.
13. Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM, For-The Bimatoprost Circadian IOP Study Group TI. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial. Surv Ophthalmol, 2004;49:S26-35.
14. Denis P, Lafuma A, Berdeaux G. Medical predictive factors of glaucoma treatment costs. Journal of Glaucoma, 2004, Sous presse.